93 related articles for article (PubMed ID: 10862563)
1. Cell death and cell proliferation in the control of normal and neoplastic tissue growth.
Foster JR
Toxicol Pathol; 2000; 28(3):441-6. PubMed ID: 10862563
[TBL] [Abstract][Full Text] [Related]
2. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
Melnick RL; Huff J
Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
[TBL] [Abstract][Full Text] [Related]
3. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
[TBL] [Abstract][Full Text] [Related]
4. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
5. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferators: their biological and toxicological effects.
Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
[TBL] [Abstract][Full Text] [Related]
7. Measures of cell replication in risk/safety assessment of xenobiotic-induced, nongenotoxic carcinogenesis.
Jones HB; Eldridge SR; Butterworth BE; Foster JR
Regul Toxicol Pharmacol; 1996 Apr; 23(2):117-27. PubMed ID: 8661330
[TBL] [Abstract][Full Text] [Related]
8. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
[TBL] [Abstract][Full Text] [Related]
9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferators and receptor-mediated hepatic carcinogenesis.
Cattley RC
Toxicol Pathol; 2004; 32 Suppl 2():6-11. PubMed ID: 15503658
[TBL] [Abstract][Full Text] [Related]
11. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
[TBL] [Abstract][Full Text] [Related]
12. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
13. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
14. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
15. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis.
Roberts RA; Ganey PE; Ju C; Kamendulis LM; Rusyn I; Klaunig JE
Toxicol Sci; 2007 Mar; 96(1):2-15. PubMed ID: 17122412
[TBL] [Abstract][Full Text] [Related]
16. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
[TBL] [Abstract][Full Text] [Related]
17. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
Gonzalez FJ; Shah YM
Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
